JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study | 60 |
Total Visits Per Month
| February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | |
|---|---|---|---|---|---|---|---|
| A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study | 1 | 3 | 1 | 2 | 2 | 7 | 4 |
Top country views
| Views |
|---|
Top cities views
| Views |
|---|
